BU
BMY icon

BBVA USA’s Bristol-Myers Squibb BMY Stock Holding History

BBVA USA’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$1.46M Sell
24,613
-6,565
-21% -$432K 0.09% 217
2021
Q2 		$2.08M Buy
+31,178
New +$2.03M 0.12% 174

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BBVA USA's BMY Position: Q3 2021 in Review

BBVA USA reduced its Bristol-Myers Squibb (BMY) stake by 21% in Q3 2021, selling an estimated $432K and leaving 24,613 shares worth $1.46M. The position accounts for 0.09% of the portfolio, ranked #217.

BBVA USA first reported a position in BMY in Q2 2021 and has held it in 2 quarters since. The position peaked at $2.08M in Q2 2021. 2,293 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

  • BBVA USA held 24,613 shares of Bristol-Myers Squibb worth $1.46M as of Q3 2021.
  • BBVA USA sold 6,565 Bristol-Myers Squibb shares in Q3 2021, an estimated $432K.
  • Bristol-Myers Squibb made up 0.09% of BBVA USA's portfolio in Q3 2021, its #217 holding.
  • BBVA USA first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 2 quarters since.
  • BBVA USA's Bristol-Myers Squibb position peaked at $2.08M in Q2 2021.
  • 2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.